This Issue At A Glance

Vinciguerra et al (p. 908) evaluated the 4-year outcomes of corneal cross-linking (CXL) for progressive keratoconus, focusing on results according to age. They found that CXL was effective in stabilizing ectatic disease progression in all age groups, while better functional and morphological results occurred in patients between ages 18 and 39. The study involved 400 eyes of 301 patients stratified into 4 different age groups: under 18, 18–9, 30–39, and over 40 years. All age groups experienced a significant improvement in best corrected visual acuity (BCVA). Additionally, patients demonstrated a (Read more...)

Full Story →